Eli Lilly and Company has announced a $30 million commitment over five years to fight the rising burden of non-communicable diseases in developing nations including India.
The first phase of The Lilly NCD partnership will focus on improving diabetes care in targeted communities in Brazil, India, Mexico and South Africa. The partnership will focus on diabetes and, over time, cancer – two core business areas in which Lilly has deep expertise.
Pharmabiz :: Lilly to invest $30 mn to address non-communicable diseases in countries including India:
No comments:
Post a Comment